| BRMAX | VIMSX | BRMAX / VIMSX | |
| Total Expense Ratio | 0.36 | 0.17 | 212% |
| Annual Report Gross Expense Ratio | 0.36 | 0.17 | 212% |
| Fund Existence | 11 years | 28 years | - |
| Gain YTD | 15.164 | 11.119 | 136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.58B | 219B | 1% |
| Annual Yield % from dividends | 1.08 | 1.20 | 90% |
| Returns for 1 year | 14.74 | 14.32 | 103% |
| Returns for 3 years | 40.70 | 46.74 | 87% |
| Returns for 5 years | 26.24 | 35.93 | 73% |
| Returns for 10 years | 104.35 | 164.90 | 63% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XLRE | 44.68 | 0.50 | +1.13% |
| State Street Real Estate Sel SectSPDRETF | |||
| ETO | 30.80 | 0.07 | +0.23% |
| Eaton Vance Tax-Advantaged Global Div Oppor Fund | |||
| JHCB | 21.24 | 0.03 | +0.14% |
| JHancock Corporate Bond ETF | |||
| BIS | 13.95 | N/A | N/A |
| ProShares UltraShort Nasdaq Biotech | |||
| AIOO | 26.27 | -0.03 | -0.13% |
| AllianzIM U.S. Equity Buffer100 Prot ETF | |||